Boxer Capital Management, LLC
63 holdingsFiling period: 2026-06-30Current AUM: $1.20Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | TNGX | TANGO THERAPEUTICS INC | 10.88M | $340.0M | $259.8M | 21.65% | -- | 2026-06-30 |
| 2 | RVMD | REVOLUTION MEDICINES INC | 500.0K | $93.6M | $102.4M | 8.54% | -- | 2026-06-30 |
| 3 | ABVX | ABIVAX SA | 605.0K | $80.6M | $64.5M | 5.38% | +405.0K | 2026-06-30 |
| 4 | — | UNIQURE NV | 1.50M | $69.2M | $69.2M | 5.77% | +841.3K | 2026-06-30 |
| 5 | KOD | KODIAK SCIENCES INC | 1.48M | $57.6M | $48.7M | 4.06% | +116.6K | 2026-06-30 |
| 6 | KYMR | KYMERA THERAPEUTICS INC | 429.1K | $49.2M | $48.6M | 4.05% | +100.0K | 2026-06-30 |
| 7 | DFTX | DEFINIUM THERAPEUTICS INC | 998.5K | $47.0M | $36.8M | 3.06% | +400.0K | 2026-06-30 |
| 8 | REPL | REPLIMUNE GROUP INC | 3.98M | $44.1M | $51.9M | 4.32% | +2.81M | 2026-06-30 |
| 9 | CELC | CELCUITY INC | 416.5K | $43.6M | $34.4M | 2.87% | +191.5K | 2026-06-30 |
| 10 | QTTB | Q32 BIO INC | 3.15M | $40.1M | $35.2M | 2.93% | -- | 2026-06-30 |
| 11 | CAPR | CAPRICOR THERAPEUTICS INC | 1.40M | $33.6M | $11.9M | 1.00% | +805.2K | 2026-06-30 |
| 12 | PGEN | PRECIGEN INC | 5.15M | $29.4M | $36.1M | 3.00% | +1.65M | 2026-06-30 |
| 13 | CORT | CORCEPT THERAPEUTICS INC | 335.5K | $29.2M | $37.2M | 3.10% | +85.5K | 2026-06-30 |
| 14 | SRZN | Surrozen Inc. | 1.11M | $27.0M | $18.5M | 1.54% | +339.4K | 2026-06-30 |
| 15 | PTGX | PROTAGONIST THERAPEUTICS INC | 170.0K | $20.8M | $24.4M | 2.03% | -- | 2026-06-30 |
| 16 | VIR | VIR BIOTECHNOLOGY INC | 1.87M | $19.0M | $19.5M | 1.62% | -- | 2026-06-30 |
| 17 | PCVX | VAXCYTE INC | 325.0K | $18.9M | $19.2M | 1.60% | -- | 2026-06-30 |
| 18 | — | UROGEN PHARMA LTD | 500.0K | $18.4M | $18.4M | 1.53% | -- | 2026-06-30 |
| 19 | CRVS | CORVUS PHARMACEUTICALS INC | 1.10M | $16.4M | $14.2M | 1.19% | -- | 2026-06-30 |
| 20 | PTCT | PTC THERAPEUTICS INC | 200.0K | $16.3M | $13.1M | 1.09% | -- | 2026-06-30 |
| 21 | PRAX | PRAXIS PRECISION MEDICINES I | 46.5K | $15.6M | $14.5M | 1.21% | -- | 2026-06-30 |
| 22 | AMLX | AMYLYX PHARMACEUTICALS INC | 800.0K | $14.4M | $26.5M | 2.21% | -- | 2026-06-30 |
| 23 | OCUL | OCULAR THERAPEUTIX INC | 1.30M | $12.8M | $13.2M | 1.10% | +950.0K | 2026-06-30 |
| 24 | IRD | OPUS GENETICS INC | 2.81M | $11.6M | $16.4M | 1.37% | +565.0K | 2026-06-30 |
| 25 | PALI | PALISADE BIO INC | 4.80M | $10.0M | $9.7M | 0.81% | -- | 2026-06-30 |
← Scroll →
Page 1 of 3